Chronic Pulmonary Aspergillosis: An Update on Diagnosis and Treatment

被引：44

作者：

Godet, Cendrine ^{[1
]}

Philippe, Bruno ^{[2
]}

Laurent, Francois ^{[3
,4
]}

Cadranel, Jacques ^{[5
,6
]}

机构：

[1] CHU La Miletrie, Dept Infect Dis, Poitiers, France

[2] Rene Dubos Hosp, Dept Pneumol, Pontoise, France

[3] Univ Hosp Bordeaux, Haut Leveque Hosp, Dept Diagnost & Therapeut Imaging, Bordeaux, France

[4] Univ Victor Segalen, Bordeaux, France

[5] Hop Tenon, AP HP, Serv Pneumol, FR-75970 Paris 20, France

[6] Univ Paris 06, Fac Med Pierre & Marie Curie, Paris, France

来源：

RESPIRATION | 2014年 / 88卷 / 02期

关键词：

Chronic pulmonary aspergillosis; Aspergilloma; Antifungal treatment; SURGICAL-TREATMENT; CLINICAL CHARACTERISTICS; GALACTOMANNAN ANTIGEN; PRACTICE GUIDELINES; FUNGAL-INFECTIONS; SEVERE HEMOPTYSIS; CHRONIC CAVITARY; ITRACONAZOLE; SPECTRUM; MANAGEMENT;

D O I：

10.1159/000362674

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Chronic pulmonary aspergillosis (CPA) affects individuals with non-systemic or mildly systemic immunodepression or altered pulmonary integrity due to underlying disease. It has been reported with a variety of clinical and radiological patterns. The condition should be distinguished from simple aspergilloma and allergic bronchopulmonary aspergillosis as well as invasive aspergillosis in severely immunocompromised patients. CPA generally requires long-term antifungal treatment and surgery may be considered. Life-threatening haemoptysis may be prevented by bronchial arteriography with embolisation. However, currently there are no documented treatment recommendations for CPA. This review provides an up-to-date practical overview of this condition, including a comprehensive update on diagnosis and management. (C) 2014 S. Karger AG, Basel

引用

页码：162 / 174

页数：13

共 50 条

[1] Update on the treatment of chronic pulmonary aspergillosis
Armstrong-James, Darius
Kosmidis, Chris
Bromley, Mike
CURRENT OPINION IN INFECTIOUS DISEASES, 2023, 36 (02) : 146 - 151
[2] Diagnosis of Chronic Pulmonary Aspergillosis: Challenges and Limitations Response to "Diagnosis of Chronic Pulmonary Aspergillosis: Which Is the Best Investigation?" and "Diagnosis of Chronic Pulmonary Aspergillosis" Reply
De Oliveira, Vitor Falcao
Magri, Marcello Mihailenko Chaves
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2023, 108 (06): : 1302 - 1303
[3] Diagnosis of Chronic Pulmonary Aspergillosis
Bongomin, Felix
Muzoora, Conrad K.
Hamer, Davidson H.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2023, 108 (06): : 1301 - 1301
[4] Chronic pulmonary aspergillosis update: A year in review
Barac, Aleksandra
Kosmidis, Chris
Alastruey-Izquierdo, Ana
Salzer, Helmut J. F.
MEDICAL MYCOLOGY, 2019, 57 : S104 - S109
[5] Pulmonary aspergillosis: diagnosis and treatment
Lamoth, Frederic
Calandra, Thierry
EUROPEAN RESPIRATORY REVIEW, 2022, 31 (166):
[6] Chronic pulmonary aspergillosis in Taiwan: Disease burden, diagnosis, treatment, and outcomes
Lai, Chih-Cheng
Hsueh, Po-Ren
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2024, 57 (06) : 833 - 839
[7] DIAGNOSIS AND TREATMENT OF INVASIVE PULMONARY ASPERGILLOSIS
Porquera, Eva M. Carmona
RESPIROLOGY, 2019, 24 : 262 - 262
[8] Progress in the Diagnosis and Treatment of Pulmonary Aspergillosis
Feng, Xiaobo
Yao, Zhirong
Liao, Wanqing
CURRENT RESPIRATORY MEDICINE REVIEWS, 2012, 8 (05) : 346 - 355
[9] Diagnosis and Treatment of Pulmonary Aspergillosis Syndromes
Patterson, Karen C.
Strek, Mary E.
CHEST, 2014, 146 (05) : 1358 - 1368
[10] Pathophysiology, diagnosis, and management of chronic pulmonary Aspergillosis
Izumikawa, Koichi
MEDICAL MYCOLOGY, 2022, 60 (SUPP 1) : 35 - 35

← 1 2 3 4 5 →